أخبار السوق

تابع أحدث الأخبار المالية والاقتصادية وتحديثات الأسواق والتقارير والتحليلات على PipVero.

المصدر: Kitco وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Gold's rally has further to run as debt, de-dollarization fuel secular bull market: Gabelli's Mancini

Gold's rally has further to run as debt, de-dollarization fuel secular bull market: Gabelli's Mancini

Gold is attracting renewed investor interest as prices climbed above $4,250 an ounce on Wednesday, marking a seven-week high. While the precious metal still faces short-term headwinds from monetary policy uncertainty, one fund manager argues that the powerful forces underpinning gold's secular bull market remain firmly in place.

الرموز ذات الصلة 1
AAAU AAAU
المصدر: Kitco
زيارة المصدر
تعليق
المصدر: PRNewsWire وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Blue Owl Technology Finance Corp. Announces June 30, 2026 Financial Results

Blue Owl Technology Finance Corp. Announces June 30, 2026 Financial Results

NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Blue Owl Technology Finance Corp. (NYSE: OTF) ("OTF" or the "Company") today announced financial results for its second quarter ended June 30, 2026. SECOND QUARTER 2026 HIGHLIGHTS  Second quarter GAAP net investment income ("NII") per share of $0.30 Second quarter adjusted NII per share(1) increased to $0.30, as compared to the prior quarter of $0.29 Dividends totaled $0.40 per share, including a base dividend of $0.35 per share and a special dividend of $0.05 per share that was declared in connection with the listing, representing an annualized dividend yield of 9.7%(2) Net asset value ("NAV") per share was stable at $16.48, as compared to $16.49 as of March 31, 2026 New investment commitments were $852 million and sales and repayments were $222 million Net debt-to-equity ended at 0.93x, as compared with 0.85x as of March 31, 2026 Investments on non-accrual represented 0.6% and 0.1% of the portfolio at cost and fair value, respectively, as compared to 0.3% and 0.1% as of March 31, 2026 Repurchased $55 million of common stock during the quarter, which was accretive to NAV per share in the second quarter Enhanced funding flexibility through an amended and extended revolving credit facility with all banking partners renewing commitments, the issuance of $500 million of unsecured debt and the addition of $150 million through a secured financing On June 12, 2026, all remaining pre-listing share lock-ups expired, resulting in 100% of OTF's float being available for trading "OTF's second quarter stability reflected the strong credit quality of our portfolio, with non-accruals among the lowest in the industry and borrower fundamentals remaining strong," said Craig W.

الرموز ذات الصلة 1
OTF OTF
المصدر: PRNewsWire
زيارة المصدر
تعليق
المصدر: Newsfile Corp وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Wise Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - WSE

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Wise Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - WSE

New York, New York--(Newsfile Corp. - August 5, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Wise Group plc (NASDAQ: WSE) between May 11, 2026 and July 23, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

الرموز ذات الصلة 1
WPLCF WPLCF
المصدر: Newsfile Corp
زيارة المصدر
تعليق
المصدر: Proactive Investors وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
AppLovin reports second quarter revenue below Wall Street estimates

AppLovin reports second quarter revenue below Wall Street estimates

AppLovin Corp (NASDAQ:APP) shares plunged more than 24% in after-hours trading on Wednesday after the mobile advertising and marketing platform reported second quarter revenue below Wall Street expectations, despite posting strong year-over-year growth and earnings in line with estimates. AppLovin reported revenue of $1.924 billion for the quarter ended June 30, up 53% from $1.259 billion a year earlier but below the $1.94 billion consensus estimate.

الرموز ذات الصلة 1
APP APP
المصدر: Proactive Investors
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Macerich's Q2 FFO & Revenues Beat Estimates on Strong Portfolio NOI

Macerich's Q2 FFO & Revenues Beat Estimates on Strong Portfolio NOI

MAC's Q2 FFO and revenues top estimates as stronger portfolio NOI, occupancy gains and tenant demand fuel growth.

الرموز ذات الصلة 1
MAC MAC
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Astec Industries, Inc. (ASTE) Q2 2026 Earnings Call Transcript

Astec Industries, Inc. (ASTE) Q2 2026 Earnings Call Transcript

Astec Industries, Inc. (ASTE) Q2 2026 Earnings Call Transcript

الرموز ذات الصلة 1
ASTE ASTE
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Vishay Intertechnology, Inc. (VSH) Q2 2026 Earnings Call Transcript

Vishay Intertechnology, Inc. (VSH) Q2 2026 Earnings Call Transcript

Vishay Intertechnology, Inc. (VSH) Q2 2026 Earnings Call Transcript

الرموز ذات الصلة 1
VSH VSH
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Zacks Investment Research وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up

HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up

HRMY tops Q2 estimates as Wakix demand fuels 30% revenue growth. A growing pipeline, BP-205 progress and reaffirmed 2026 guidance add momentum.

الرموز ذات الصلة 1
HRMY HRMY
المصدر: Zacks Investment Research
زيارة المصدر
تعليق
المصدر: Seeking Alpha وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated

Harmony Biosciences: Management Raised Its Game, But The Stock Has Already Rerated

Harmony Biosciences Holdings, Inc. has now elevated BP-205, its orexin-2 receptor agonist, to lead the pipeline. HRMY management has become even more specific about business development—exactly the kind of thing I thought was missing earlier. My updated valuation suggests most of the improvement is now reflected in the stock. I am, therefore, upgrading HRMY from Sell to Hold.

الرموز ذات الصلة 1
HRMY HRMY
المصدر: Seeking Alpha
زيارة المصدر
تعليق
المصدر: Forbes وكالة أنباء
قبل شهر واحد
الأسهم أهمية متوسطة
SpaceX Shares Plunge 13% As Elon Musk's Fortune Sheds $80 Billion—Here's What Analysts Are Saying

SpaceX Shares Plunge 13% As Elon Musk's Fortune Sheds $80 Billion—Here's What Analysts Are Saying

Some brokerages appeared optimistic about SpaceX's quarterly earnings: JPMorgan analysts, who lifted their price target for shares to $240 from $225, wrote SpaceX is benefiting from “extreme vertical integration” while noting its “pace of change in AI is incredibly fast,” and that a step-up in AI infrastructure and higher monetization could push SpaceX's AI revenue to $100 billion in 2027. Wells Fargo analysts cut their price target for SpaceX shares to $215 from $230 amid broader caution about its AI spending, noting that SpaceX was “off to an ambitious start” and that revenue projections for 2027 and 2028 were higher than expected, but so were capital expenditure estimates.

الرموز ذات الصلة 1
SPCX SPCX
المصدر: Forbes
زيارة المصدر
تعليق